Skip to main content Help with accessibility Skip to main navigation

Botulinum Toxin Type A

Red

Brand:

All brands within licensed indications only

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Central nervous system

Background

NICE CG186 does not make a recommendation on use of botulinum toxin A for spasticity in MS . Use has been approved locally after a review of audit data, provided:
  • treatment is restricted to those patients who have failed or could not have other treatments
  • treatment is only initiated by an appropriate specialist with experience in use of botulinum toxin A, that there are clearly defined goals of treatment — set prior to initiation and against which patients will be reviewed at each injection cycle.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

Red
Pending
Red
Red
Pending
Red
Red
Red
What do the colours mean?

Last Updated: 01 - Mar - 2014